These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 12683617)

  • 1. Brain natriuretic peptide concentration in dogs with heart disease and congestive heart failure.
    MacDonald KA; Kittleson MD; Munro C; Kass P
    J Vet Intern Med; 2003; 17(2):172-7. PubMed ID: 12683617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma atrial and brain natriuretic peptide levels in dogs with congestive heart failure.
    Asano K; Masuda K; Okumura M; Kadosawa T; Fujinaga T
    J Vet Med Sci; 1999 May; 61(5):523-9. PubMed ID: 10379945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased NT-proANP predicts risk of congestive heart failure in Cavalier King Charles spaniels with mitral regurgitation caused by myxomatous valve disease.
    Eriksson AS; Häggström J; Pedersen HD; Hansson K; Järvinen AK; Haukka J; Kvart C
    J Vet Cardiol; 2014 Sep; 16(3):141-54. PubMed ID: 25130405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of digoxin on atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP) and cyclic 3', 5'-guanosine monophosphate (cGMP) in patients with chronic congestive heart failure].
    Kobusiak-Prokopowicz M; Swidnicka-Szuszkowska B; Mysiak A
    Pol Arch Med Wewn; 2001 Jun; 105(6):475-82. PubMed ID: 11865578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective clinical evaluation of an ELISA B-type natriuretic peptide assay in the diagnosis of congestive heart failure in dogs presenting with cough or dyspnea.
    DeFrancesco TC; Rush JE; Rozanski EA; Hansen BD; Keene BW; Moore DT; Atkins CE
    J Vet Intern Med; 2007; 21(2):243-50. PubMed ID: 17427384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of plasma N-terminal pro-B-type natriuretic peptide concentration with mitral regurgitation severity and outcome in dogs with asymptomatic degenerative mitral valve disease.
    Chetboul V; Serres F; Tissier R; Lefebvre HP; Sampedrano CC; Gouni V; Poujol L; Hawa G; Pouchelon J-
    J Vet Intern Med; 2009; 23(5):984-94. PubMed ID: 19572913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical correlates of elevated plasma natriuretic peptides and Big endothelin-1 in a population of ambulatory patients with heart failure. A substudy of the Italian Network on Congestive Heart Failure (IN-CHF) registry. IN-CHF Investigators.
    Masson S; Gorini M; Salio M; Lucci D; Latini R; Maggioni AP
    Ital Heart J; 2000 Apr; 1(4):282-8. PubMed ID: 10824729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnostic value of plasma concentration of pro-brain natriuretic peptide in congestive heart failure in pediatric patients with ventricular septal defects].
    Wu YR; Chen SB; Huang MR; Zhang YQ; Sun K; Chen S
    Zhonghua Er Ke Za Zhi; 2005 Mar; 43(3):161-4. PubMed ID: 15833183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term hemodynamic and neuroendocrine effects of pimobendan and benazapril in dogs with myxomatous mitral valve disease and congestive heart failure.
    Häggström J; Lord PF; Höglund K; Ljungvall I; Jöns O; Kvart C; Hansson K
    J Vet Intern Med; 2013; 27(6):1452-62. PubMed ID: 24128373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Irrelevant B-type natriuretic peptide levels in patients with mechanical prostheses in the mitral position presenting with congestive heart failure.
    Higashi K; Tanaka H; Shimokawahara H; Nuruki N; Kashima K; Sonoda M; Nakamura K; Tsubouchi H
    Circ J; 2010 Aug; 74(8):1584-90. PubMed ID: 20606330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of brain natriuretic peptide and serum triiodothyronine in the diagnosis and prognosis of chronic heart failure.
    Du JB; Da CH; Zhao Y; Guo Y; Guo G; Ju TF; Xu YP
    Acta Cardiol; 2012 Jun; 67(3):291-6. PubMed ID: 22870736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of treatment on respiratory rate, serum natriuretic peptide concentration, and Doppler echocardiographic indices of left ventricular filling pressure in dogs with congestive heart failure secondary to degenerative mitral valve disease and dilated cardiomyopathy.
    Schober KE; Hart TM; Stern JA; Li X; Samii VF; Zekas LJ; Scansen BA; Bonagura JD
    J Am Vet Med Assoc; 2011 Aug; 239(4):468-79. PubMed ID: 21838584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of prespecified therapy escalation on plasma NT-proBNP concentrations in dogs with stable congestive heart failure due to myxomatous mitral valve disease.
    Hezzell MJ; Block CL; Laughlin DS; Oyama MA
    J Vet Intern Med; 2018 Sep; 32(5):1509-1516. PubMed ID: 30216549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Values of brain natriuretic peptide and N-terminal pro-brain natriuretic peptide in evaluation of cardiac function in children with congenital heart disease].
    Zhang SR; Zhang YH; Xu Q; Qiu HX; Chen Q
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jun; 11(6):429-32. PubMed ID: 19558803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma atrial natriuretic peptide and N-terminal pro B-type natriuretic peptide concentrations in dogs with right-sided congestive heart failure.
    Kanno N; Hori Y; Hidaka Y; Chikazawa S; Kanai K; Hoshi F; Itoh N
    J Vet Med Sci; 2016 May; 78(4):535-42. PubMed ID: 26607133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of atrial natriuretic peptide (ANP), B-type natriuretic peptide (BNP) and their correlation with lipoproteins in dogs with myxomatous mitral valve disease.
    Khaki Z; Nooshirvani P; Shirani D; Masoudifard M
    BMC Vet Res; 2022 Dec; 18(1):448. PubMed ID: 36564735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammation and its association with oxidative stress in dogs with heart failure.
    Nemec Svete A; Verk B; Čebulj-Kadunc N; Salobir J; Rezar V; Domanjko Petrič A
    BMC Vet Res; 2021 Apr; 17(1):176. PubMed ID: 33902566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Carvedilol on Serum Heart-type Fatty Acid-binding Protein, Brain Natriuretic Peptide, and Cardiac Function in Patients With Chronic Heart Failure.
    Sun YP; Wei CP; Ma SC; Zhang YF; Qiao LY; Li DH; Shan RB
    J Cardiovasc Pharmacol; 2015 May; 65(5):480-4. PubMed ID: 25945865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined Assessment of Relaxin and B-Type Natriuretic Peptide Improves Diagnostic Value in Patients With Congestive Heart Failure.
    Han L; Luo J; Bai S; Jia Y; Chen X; Zhao Y; Chen L; Zhu X; Li Y; Jiang Y; Li X; Yang M; Li D; Teng X; Qi Y
    Am J Med Sci; 2017 Nov; 354(5):480-485. PubMed ID: 29173360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinguishing cardiac and noncardiac dyspnea in 48 dogs using plasma atrial natriuretic factor, B-type natriuretic factor, endothelin, and cardiac troponin-I.
    Prosek R; Sisson DD; Oyama MA; Solter PF
    J Vet Intern Med; 2007; 21(2):238-42. PubMed ID: 17427383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.